Philip Kantoff

Philip Kantoff is a distinguished medical professional currently serving as Co-Founder and Chief Executive Officer of Convergent Therapeutics, Inc. Since November 2015, Philip Kantoff has held the position of Jerome and Nancy Kohlberg Professor Emeritus at Harvard Medical School. In addition to these roles, Philip Kantoff serves on the boards of the Prostate Cancer Foundation, ESSA Pharma, and Context Therapeutics. Prior to these appointments, Philip Kantoff was Chairman of Medicine at Memorial Sloan Kettering Cancer Center from November 2015 to June 2021 and Division Head of Solid Tumor Oncology at Dana-Farber Cancer Institute from January 1991 to November 2015. Philip Kantoff earned a Doctor of Medicine degree in Medical Oncology from The Warren Alpert Medical School of Brown University after completing education at Brown University.